EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression

Liu-Xia Yuan, Zhi-Qiang Yue, Jing-Wen Xiao, Lin-Ling Ju, Hui-Xuan Wang, Jia-Jia Tan, Feng Xiao, Lin Chen

Clinical and Experimental Medicine · 21.06.2026 · 26 (1)

DOI: 10.1007/s10238-026-02223-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 21.06.2026. Verfasst von Liu-Xia Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nantong University Special Research Fund for Clinical Medicine, Nantong Municipal Health Commission, he Health Commission of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansPrognosisFemaleGene Expression Regulation, NeoplasticCell Line, TumorMaleUp-RegulationCell ProliferationDisease ProgressionBiomarkers, TumorApoptosisMiddle Aged

Stichwörter der Autor:innen

BiomarkersECM2HCCPrognosistRNA fragment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, China.
  • Department of Gastrointestinal Surgery, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, China.
  • Department of Pathology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, China.
  • Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, China. xiaobei227@sina.com.

Förderung

  • Nantong University Special Research Fund for Clinical Medicine
  • Nantong Municipal Health Commission
  • he Health Commission of Jiangsu Province
  • the Nantong Science and Technology Bureau

Zitieren

APA

Yuan, L. X., Yue, Z. Q., Xiao, J. W., Ju, L. L., Wang, H. X., Tan, J. J., Xiao, F., & Chen, L. (2026). tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression. Clinical and Experimental Medicine, 26(1). https://doi.org/10.1007/s10238-026-02223-2

Vancouver

Yuan LX, Yue ZQ, Xiao JW, Ju LL, Wang HX, Tan JJ, et al. tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression. Clinical and Experimental Medicine. 2026;26(1). doi:10.1007/s10238-026-02223-2

BibTeX
@article{Yuan2026,
  author = {Yuan, Liu-Xia and Yue, Zhi-Qiang and Xiao, Jing-Wen and Ju, Lin-Ling and Wang, Hui-Xuan and Tan, Jia-Jia and Xiao, Feng and Chen, Lin},
  title = {tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression},
  journal = {Clinical and Experimental Medicine},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1007/s10238-026-02223-2}
}
Kostenlos starten →